NCT06130683View on ClinicalTrials.gov

Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism

Active, not recruitingOBSERVATIONAL
Enrollment

12

Participants

Timeline

Start Date

November 10, 2023

Primary Completion Date

December 8, 2024

Study Completion Date

July 31, 2025

Conditions
Secondary Hyperparathyroidism
Interventions
OTHER

Single-cell sequencing

Single-cell sequencing technology can reveal the gene structure and gene expression status of individual cells, reflecting the heterogeneity between cells.

Trial Locations (1)

Unknown

China and Japan Friendship Hospital, Beijing

All Listed Sponsors
lead

China-Japan Friendship Hospital

OTHER

NCT06130683 - Single-Cell Sequence Technology Used to Reveal Heterogeneity of Secondary Hyperparathyroidism | Biotech Hunter | Biotech Hunter